玮俊生物科技(00660)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

00660 玮俊生物科技

交易中 12-23 11:09:40

0.075

+0.001

+1.35%

最高0.075	最低0.074	成交量6.00万
今开0.074	昨收0.074	日振幅1.35%
总市值1,286万	流通市值1,286万	总股本1.71亿
成交额4,460	换手率0.03%	流通股本1.71亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"00660","market":"HK","secType":"STK","nameCN":"玮俊生物科技","latestPrice":0.075,"timestamp":1734921772644,"preClose":0.074,"halted":0,"volume":60000,"delay":0,"floatShares":171476453,"shares":171476453,"eps":-0.258,"marketStatus":"交易中","marketStatusCode":2,"change":0.001,"latestTime":"12-23 11:09:40","open":0.074,"high":0.075,"low":0.074,"amount":4460,"amplitude":0.013514,"askPrice":0.142,"askSize":180000,"bidPrice":0.075,"bidSize":20000,"shortable":0,"etf":0,"ttmEps":-0.258,"exchange":"SEHK","tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1734926400000},"adr":0,"adjPreClose":0.074,"openAndCloseTimeList":[[1734917400000,1734926400000],[1734930000000,1734940800000]],"volumeRatio":0.469105,"lotSize":20000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/00660","defaultTab":"news","newsList":[{"id":"2493727992","title":"玮俊生物科技(00660)年度拥有人应占亏损4421.2万港元 同比扩大1.86倍 12月23日复牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2493727992","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493727992?lang=zh_cn&edition=full","pubTime":"2024-12-23 08:38","pubTimestamp":1734914325,"startTime":"0","endTime":"0","summary":"智通财经APP讯，玮俊生物科技(00660)发布公告，该公司股份将于2024年12月23日上午9时正起恢复买卖。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1228184.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1237","00660"],"gpt_icon":0},{"id":"2493249504","title":"《业绩》玮俊生物科技(00660.HK)全年亏损扩至4,421万元  股份复牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2493249504","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493249504?lang=zh_cn&edition=full","pubTime":"2024-12-22 20:55","pubTimestamp":1734872100,"startTime":"0","endTime":"0","summary":"玮俊生物科技(00660.HK) 公布6月止财政年度业绩，收入录得3.7亿元，按年下降52.2%。亏损由上年度1,543万元，扩至4,421万元，每股亏损25.8仙。不派末期息。过往派息公布日期派息事项派息内容2024/02/29中期业绩无派息2023/09/29末期业绩无派息2023/02/28中期业绩无派息2023/01/10特别业绩合并：10股合并为1股公司股份已申请周一(23日)起恢复买卖。(de/d)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20221130113843525_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20221130113843525_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1405746/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1237","00660"],"gpt_icon":0},{"id":"2492144316","title":"玮俊生物科技年度收入约3.7亿港元 同比减少52.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492144316","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492144316?lang=zh_cn&edition=full","pubTime":"2024-12-20 21:07","pubTimestamp":1734700023,"startTime":"0","endTime":"0","summary":"格隆汇12月20日丨玮俊生物科技公告，截至2024年6月30日止年度，集团录得收入约370.0百万港元，较上一年度减少52.2%。收入下降主要归因于报告期内变性淀粉及其他生化产品的市场需求疲软及消费量下降。这一决定亦导致收入大幅下降。公司拥有人应占亏损截至2024年6月30日止年度约为44.2百万港元，而上年度的亏损约为15.4百万港元。亏损增加主要由于报告年度内非金融资产减值亏损的确认。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220211036ab8733f4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220211036ab8733f4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1237","00660"],"gpt_icon":0},{"id":"2492443166","title":"玮俊生物科技公布年度业绩 拥有人应占亏损4421.2万港元 同比扩大1.86倍","url":"https://stock-news.laohu8.com/highlight/detail?id=2492443166","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492443166?lang=zh_cn&edition=full","pubTime":"2024-12-20 20:52","pubTimestamp":1734699170,"startTime":"0","endTime":"0","summary":"智通财经APP讯， 玮俊生物科技 (00660.HK)公布截至2024年6月30日止年度业绩，收入约3.7亿港元，同比减少52.17%;公司拥有人应占亏损4421.2万港元，同比扩大1.86倍;每股亏损25.8港仙。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220212423a1fe001b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220212423a1fe001b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1237","00660"],"gpt_icon":0},{"id":"2492410306","title":"玮俊生物科技(00660)公布年度业绩 拥有人应占亏损4421.2万港元 同比扩大1.86倍","url":"https://stock-news.laohu8.com/highlight/detail?id=2492410306","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492410306?lang=zh_cn&edition=full","pubTime":"2024-12-20 20:44","pubTimestamp":1734698663,"startTime":"0","endTime":"0","summary":"智通财经APP讯，玮俊生物科技(00660)公布截至2024年6月30日止年度业绩，收入约3.7亿港元，同比减少52.17%;公司拥有人应占亏损4421.2万港元，同比扩大1.86倍;每股亏损25.8港仙。公告称，收入下降主要归因于报告期内变性淀粉及其他生化产品的市场需求疲软及消费量下降。此外，作为提升整体营运效率的战略重组的一部分，集团已停止某些表现不佳的产品线。这一决定亦导致收入大幅下降。亏损增加主要由于报告年度内非金融资产减值亏损的确认。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1227962.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1237","00660"],"gpt_icon":0},{"id":"2492174371","title":"玮俊生物科技：钱盈盈辞任公司秘书及授权代表","url":"https://stock-news.laohu8.com/highlight/detail?id=2492174371","media":"格隆汇","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492174371?lang=zh_cn&edition=full","pubTime":"2024-12-19 22:37","pubTimestamp":1734619023,"startTime":"0","endTime":"0","summary":"格隆汇12月19日丨玮俊生物科技(00660.HK)公告，钱盈盈为投入更多时间于个人未来发展，辞任公司公司秘书及授权代表，于2024年12月18日起生效。【免责声明】本文仅代表作者本人观点，与和讯网无关。和讯网站对文中陈述、观点判断保持中立，不对所包含内容的准确性、可靠性或完整性提供任何明示或暗示的保证。请读者仅作参考，并请自行承担全部责任。邮箱：news_center@staff.hexun.com","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219224941a1fb5eb9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219224941a1fb5eb9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1237","00660"],"gpt_icon":0},{"id":"2492736121","title":"玮俊生物科技(00660)：钱盈盈辞任公司秘书及授权代表","url":"https://stock-news.laohu8.com/highlight/detail?id=2492736121","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492736121?lang=zh_cn&edition=full","pubTime":"2024-12-19 21:51","pubTimestamp":1734616268,"startTime":"0","endTime":"0","summary":"智通财经APP讯，玮俊生物科技(00660)公布，钱盈盈女士为投入更多时间于个人未来发展，辞任公司的公司秘书及授权代表，于2024年12月18日起生效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1227344.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1237","00660"],"gpt_icon":0},{"id":"2491466861","title":"玮俊生物科技预计年度综合净亏损5700万港元-6200万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491466861","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491466861?lang=zh_cn&edition=full","pubTime":"2024-12-16 17:47","pubTimestamp":1734342429,"startTime":"0","endTime":"0","summary":"格隆汇12月16日丨玮俊生物科技(00660.HK)公布，集团预期截至2024年6月30日止年度将录得综合净亏损介乎5700万港元至6200万港元，而截至2023年6月30日止年度净亏损约1000万港元。预期公司综合净亏损增加主要是由于(其中包括)毛利减少约1620万港元及物业、厂房及设备减值亏损约5180万港元。【免责声明】本文仅代表作者本人观点，与和讯网无关。和讯网站对文中陈述、观点判断保持中立，不对所包含内容的准确性、可靠性或完整性提供任何明示或暗示的保证。请读者仅作参考，并请自行承担全部责任。邮箱：news_center@staff.hexun.com","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216175152ab7c0025&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216175152ab7c0025&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00660","BK1237"],"gpt_icon":0},{"id":"2491657418","title":"玮俊生物科技(00660)发盈警 预期年度净亏损同比扩大至5700万至6200万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491657418","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491657418?lang=zh_cn&edition=full","pubTime":"2024-12-16 17:30","pubTimestamp":1734341433,"startTime":"0","endTime":"0","summary":"智通财经APP讯，玮俊生物科技(00660)发布公告，集团预期截至2024年6月30日止年度(本年度)将取得综合净亏损介乎5700万港元至6200万港元，而截至2023年6月30日止年度净亏损约1000万港元。公告称，预期公司综合净亏损增加主要是由于(其中包括)毛利减少约1620万港元及物业、厂房及设备减值亏损约5180万港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1225400.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1237","00660"],"gpt_icon":0},{"id":"2491665749","title":"《盈警》玮俊生物科技(00660.HK)料上年度亏损增至介乎5,700万至6,200万","url":"https://stock-news.laohu8.com/highlight/detail?id=2491665749","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491665749?lang=zh_cn&edition=full","pubTime":"2024-12-16 17:29","pubTimestamp":1734341340,"startTime":"0","endTime":"0","summary":"玮俊生物科技(00660.HK) 发盈警，预料截至2024年6月30日止年度将录得综合净亏损介乎5,700万至6,200万元，对比2023年同期净亏损为约1,000万元，净亏损增加归因于期内毛利减少，以及录得物业、厂房及设备减值亏损。(gc/a)(港股报价延迟最少十五分钟。)过往派息公布日期派息事项派息内容2024/02/29中期业绩无派息2023/09/29末期业绩无派息2023/02/28中期业绩无派息2023/01/10特别业绩合并：10股合并为1股AASTOCKS新闻","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20221130113842978_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20221130113842978_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1404411/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["00660","BK1237"],"gpt_icon":0},{"id":"2476284007","title":"玮俊生物科技(00660)：钱盈盈已获委任为公司秘书","url":"https://stock-news.laohu8.com/highlight/detail?id=2476284007","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476284007?lang=zh_cn&edition=full","pubTime":"2024-10-18 19:30","pubTimestamp":1729251023,"startTime":"0","endTime":"0","summary":"智通财经APP讯，玮俊生物科技(00660)发布公告，范德伟已辞任公司的公司秘书及香港联合交易所有限公司证券上市规则第3.05条授权代表，自2024年10月17日起生效。钱盈盈已获委任为公司秘书及授权代表，自2024年10月18日起生效。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1196159.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1237","00660"],"gpt_icon":0},{"id":"2472559731","title":"玮俊生物科技(00660)拟延迟刊发截至2024年6月30日止年度业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2472559731","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472559731?lang=zh_cn&edition=full","pubTime":"2024-10-02 09:01","pubTimestamp":1727830875,"startTime":"0","endTime":"0","summary":"智通财经APP讯，玮俊生物科技(00660)发布公告，由于公司核数师需要更多时间评估全年业绩若干方面，包括外部审核确认函件部分仍未收回及因新委聘核数师首年并延迟获公司委聘进行审核工作，部分工作仍需时完成，故集团的全年业绩将延迟发布。因此，公司未能于2024年9月30日或之前发布全年业绩。年报亦可能因而延迟寄发。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1189619.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1237","00660"],"gpt_icon":0},{"id":"2472515795","title":"玮俊生物科技(00660.HK)今早起停牌 待发年度业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2472515795","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472515795?lang=zh_cn&edition=full","pubTime":"2024-10-02 09:00","pubTimestamp":1727830800,"startTime":"0","endTime":"0","summary":"玮俊生物科技(00660.HK) 今日(2日)早上9时起停牌，以待刊发截至今年6月底止年度的初步业绩。公司指出，由于核数师需要更多时间评估全年业绩若干方面，包括外部审核确认函件部分仍未收回及因新委聘核数师首年并延迟获公司委聘进行审核工作，部分工作仍需时完成，故集团的全年业绩将延迟发布。因此，公司未能于9月30日或之前发布全年业绩。年报亦可能因而延迟寄发。(jl/w)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20221130113842978_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20221130113842978_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1385288/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1237","00660"],"gpt_icon":0},{"id":"2472559908","title":"玮俊生物科技(00660)10月2日起停牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2472559908","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472559908?lang=zh_cn&edition=full","pubTime":"2024-10-02 08:57","pubTimestamp":1727830649,"startTime":"0","endTime":"0","summary":"智通财经APP讯，玮俊生物科技(00660)发布公告，该公司的股份将于2024年10月2日上午9时正起暂停买卖。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1189617.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00660","BK1237"],"gpt_icon":0},{"id":"2471812192","title":"玮俊生物科技股价重挫19.12% 市值跌180.3万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2471812192","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2471812192?lang=zh_cn&edition=full","pubTime":"2024-09-30 10:59","pubTimestamp":1727665170,"startTime":"0","endTime":"0","summary":"2024年09月30日早盘10时59分，玮俊生物科技股票出现波动，股价急速跳水19.12%。截至发稿，该股报0.055港元/股，成交量14万股，换手率0.08%，振幅20.59%。玮俊生物科技股票所在的特殊化工用品行业中，整体涨幅为0.07%。其相关个股中，武汉有机、东岳集团、荣晖国际涨幅较大，振幅较大的相关个股有玮俊生物科技、GHW INTL、武汉有机，振幅分别为20.59%、17.40%、15.51%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024093010593098e39a55&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024093010593098e39a55&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1237","00660"],"gpt_icon":0},{"id":"2470174337","title":"玮俊生物科技盘中异动 大幅下挫6.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2470174337","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470174337?lang=zh_cn&edition=full","pubTime":"2024-09-27 10:14","pubTimestamp":1727403253,"startTime":"0","endTime":"0","summary":"2024年09月27日早盘10时14分，玮俊生物科技股票出现波动，股价大幅跳水6.17%。截至发稿，该股报0.076港元/股，成交量0股，换手率0.00%，振幅0.00%。玮俊生物科技股票所在的特殊化工用品行业中，整体涨幅为0.07%。玮俊生物科技公司简介：玮俊生物科技有限公司是一家主要从事制造及销售变性淀粉的香港投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240927101413ab665312&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240927101413ab665312&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00660","BK1237"],"gpt_icon":0},{"id":"2470206125","title":"玮俊生物科技盘中异动 临近收盘大幅上涨5.19%报0.081港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2470206125","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470206125?lang=zh_cn&edition=full","pubTime":"2024-09-26 15:41","pubTimestamp":1727336474,"startTime":"0","endTime":"0","summary":"2024年09月26日临近收盘15时41分，玮俊生物科技股票出现波动，股价大幅拉升5.19%。截至发稿，该股报0.081港元/股，成交量12.1万股，换手率0.07%，振幅0.00%。资金方面，该股资金流入9360港元，流出0港元。玮俊生物科技股票所在的特殊化工用品行业中，整体涨幅为0.17%。其相关个股中，GHW INTL、长安仁恒、东岳集团涨幅较大，振幅较大的相关个股有GHW INTL、长安仁恒、江苏创新，振幅分别为46.52%、24.80%、14.86%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092615411498e390fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092615411498e390fb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00660","BK1237"],"gpt_icon":0},{"id":"2468365667","title":"玮俊生物科技(00660.HK)财务总监辞任 可能延发全年业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2468365667","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468365667?lang=zh_cn&edition=full","pubTime":"2024-09-20 09:00","pubTimestamp":1726794000,"startTime":"0","endTime":"0","summary":"玮俊生物科技(00660.HK) 公布，其财务总监由于家庭原因自9月14日起辞任，导致公司向核数师提供资料及文件产生阻碍，故公司需要额外时间落实截至今年6月底止年度的经审核末期业绩及其发布，并可能晚于9月30日发表全年业绩。公司正与核数师密切合作，向其提供所有要求的资料及文件，以尽快完成审核程序。但是，全年业绩的预计公布日期需与核数师进一步确定，并将会另行公告。(jl/a)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20221130113842978_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20221130113842978_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1382549/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1237","00660"],"gpt_icon":0},{"id":"2468644651","title":"玮俊生物科技公布可能延迟刊发全年业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2468644651","media":"新浪网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468644651?lang=zh_cn&edition=full","pubTime":"2024-09-20 08:40","pubTimestamp":1726792847,"startTime":"0","endTime":"0","summary":"玮俊生物科技发布公告，公司财务总监由于家庭原因自2024年9月14日起辞任，导致公司向核数师提供资料及文件产生阻碍，故公司需要额外时间落实截至2024年6月30日止年度的经审核末期业绩及其发布，并可能晚于2024年9月30日发表全年业绩。公司正与核数师密切合作，向其提供所有要求的资料及文件，以尽快完成审核程序。但是，全年业绩的预计公布日期需与核数师进一步确定，并将会另行公告。请读者仅作参考，并请自行承担全部责任。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092009134195708059&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092009134195708059&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00660","BK1237"],"gpt_icon":0},{"id":"2468534574","title":"玮俊生物科技(00660)：可能延迟刊发全年业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2468534574","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468534574?lang=zh_cn&edition=full","pubTime":"2024-09-19 21:08","pubTimestamp":1726751331,"startTime":"0","endTime":"0","summary":"智通财经APP讯，玮俊生物科技(00660)发布公告，公司财务总监由于家庭原因自2024年9月14日起辞任，导致公司向核数师提供资料及文件产生阻碍，故公司需要额外时间落实截至2024年6月30日止年度的经审核末期业绩及其发布，并可能晚于2024年9月30日发表全年业绩。公司正与核数师密切合作，向其提供所有要求的资料及文件，以尽快完成审核程序。但是，全年业绩的预计公布日期需与核数师进一步确定，并将会另行公告。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1184887.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1237","00660"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.0660.hk","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":-0.075},{"period":"6month","weight":-0.408},{"period":"1year","weight":-0.4714},{"period":"ytd","weight":-0.4861}],"compareEarnings":[{"period":"1week","weight":-0.0125},{"period":"1month","weight":0.0008},{"period":"3month","weight":0.0801},{"period":"6month","weight":0.0939},{"period":"1year","weight":0.1865},{"period":"ytd","weight":0.1568}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"玮俊生物科技有限公司是一家主要从事制造及销售变性淀粉的香港投资控股公司。该公司连同其附属公司主要从事制造及销售变性淀粉及其他生化产品,例如生化精炼油产品。此外，该公司还从事买卖电子元件、组件和器件及电器。","yearOnYearQuotes":[{"month":1,"riseRate":0.354839,"avgChangeRate":0.059889},{"month":2,"riseRate":0.387097,"avgChangeRate":0.103092},{"month":3,"riseRate":0.3125,"avgChangeRate":0.102447},{"month":4,"riseRate":0.258065,"avgChangeRate":0.030601},{"month":5,"riseRate":0.451613,"avgChangeRate":0.015588},{"month":6,"riseRate":0.5,"avgChangeRate":0.045722},{"month":7,"riseRate":0.3125,"avgChangeRate":0.02704},{"month":8,"riseRate":0.15625,"avgChangeRate":-0.050273},{"month":9,"riseRate":0.25,"avgChangeRate":-0.046343},{"month":10,"riseRate":0.322581,"avgChangeRate":0.020524},{"month":11,"riseRate":0.290323,"avgChangeRate":-0.009509},{"month":12,"riseRate":0.21875,"avgChangeRate":-0.034068}],"exchange":"SEHK","name":"玮俊生物科技","nameEN":"WAI CHUN BIOTEC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"玮俊生物科技(00660)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供玮俊生物科技(00660)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"玮俊生物科技,00660,玮俊生物科技股票,玮俊生物科技股票老虎,玮俊生物科技股票老虎国际,玮俊生物科技行情,玮俊生物科技股票行情,玮俊生物科技股价,玮俊生物科技股市,玮俊生物科技股票价格,玮俊生物科技股票交易,玮俊生物科技股票购买,玮俊生物科技股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"玮俊生物科技(00660)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供玮俊生物科技(00660)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}